Skip to content

Clinical trials

Metabolic Diseases trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Country / region: Brazil Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20082
20091
20111
20141
20152
20161
20172
20182
20201
20212
20223
20244
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting4
Unknown status2
Active, not recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Kastle Therapeutics, LLC2
University of Sao Paulo2
University of Sao Paulo General Hospital2
89bio, Inc.1
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
BiomeHub Biotechnology Company1
Federal University of Minas Gerais1
Federal University of Rio Grande do Sul1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases25
Diabetes Mellitus9
Diabetes Mellitus, Type 29
Glucose Metabolism Disorders9
Endocrine System Diseases7
Genetic Diseases, Inborn5
Lipid Metabolism Disorders5
Metabolism, Inborn Errors5
Hyperlipidemias3
Infant, Newborn, Diseases3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.